Discussion on economic value of pharmaceutical care in medical institutions based on cost-benefit analysis
- VernacularTitle:基于成本-效益分析的医疗机构药学服务经济价值探讨
- Author:
Lingxi KONG
1
;
Hongmei WANG
1
;
Min PENG
2
;
Feng QIU
1
;
Jiadan YANG
1
;
Xuefeng SHAN
1
Author Information
1. Dept. of Pharmacy，the First Affiliated Hospital of Chongqing Medical University，Chongqing 400016，China
2. Chongqing Pharmaceutical Sc ience Technology School，Chongqing 400062，China
- Publication Type:Journal Article
- Keywords:
pharmaceutical care;
cost;
cost-benefit;
economic evaluation;
quality evaluation
- From:
China Pharmacy
2022;33(14):1769-1775
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To evalu ate relat ed researches about the cost- benefit of pharmaceutical care in medical institutions with cost- benefit analysis，in order to provide evidence-based basis for related policy decisions and provide methodological reference for the cost- benefit evaluation of pharmaceutical care in the future. METHODS Retrieved from PubMed ，Embase，the Cochrane Library ，CBM，Wanfang database ，VIP and CNKI ，cost-benefit analysis was used to evaluate the researches about the cost-benefit of pharmaceutical care in medical institutions. Two researchers independently screened the research and extracted data according to the “Consolidated Health Economic Evaluation Reporting Standards Checklist ”. The quality of included studies was scored and evaluated systematically. RESULTS A total of 46 studies from 17 countries were included. Most of them came from the United States （21.74％），China（19.57％）and France （8.70％）. Average score of 46 literature was 14.30，of which 1 literature was excellent ，5 literature were good ，25 literature were qualified and 14 literature were unqualified. There were 25 research protocols of prospective study type ；the type of pharmaceutical care involved mostly was pharmaceutical monitoring （60.87％）， followed by prescription review （23.91％），medication reconciliation （8.70％）and outpatient pharmacy （6.52％）were less. The median cost-benefit ratio of pharmaceutical care was 5.05 （3.08，11.28）. CONCLUSIONS Pharmaceutical care shows good economic value ，and pharmacists have played an important role in saving medical resources ，but the design level and report quality of the existing studies need to be improved.
